<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Pharmaceutical Commerce articles</title><description>Pharmaceutical Commerce articles</description><link>https://www.pharmaceuticalcommerce.com/news</link><category>Pharmaceutical Commerce articles</category><copyright>© 2026 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.</copyright><lastBuildDate>Mon, 12 Oct 2026 21:40:50 +0000</lastBuildDate><ttl>5</ttl><atom:link href="https://www.pharmaceuticalcommerce.com/rss.xml" rel="self" type="application/rss+xml"/><language>en-us</language><image><title>Pharmaceutical Commerce articles</title><width>144</width><height>47</height><link>https://www.pharmaceuticalcommerce.com/news</link><url>https://www.pharmaceuticalcommerce.com/logo.webp</url></image><item><title>&lt;![CDATA[Smart Locks, Escorts or Parcel? Matching Security to the Shipment]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/smart-locks-escorts-or-parcel-matching-security-to-the-shipment</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/smart-locks-escorts-or-parcel-matching-security-to-the-shipment</guid><description>&lt;![CDATA[Octapharma USA&apos;s Kerem Tokel explains how product value and supply risk should shape freight security, and why complacency remains a persistent gap.]]&gt;</description><pubDate>Mon, 12 Oct 2026 16:34:18 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[How Lanes and Duration Shape Cold Chain Packaging Selection]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/how-lanes-and-duration-shape-cold-chain-packaging-choices</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/how-lanes-and-duration-shape-cold-chain-packaging-choices</guid><description>&lt;![CDATA[At LogiPharma USA 2026, Cold Chain Technologies&apos; Vijay Paliwal explains how manufacturers should choose between reusable, single-use and active packaging.]]&gt;</description><pubDate>Mon, 12 Oct 2026 14:59:10 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[How Precision and Share of Answer Will Reshape Pharma Marketing]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/how-precision-and-share-of-answer-will-reshape-pharma-marketing</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/how-precision-and-share-of-answer-will-reshape-pharma-marketing</guid><description>&lt;![CDATA[As HCPs turn to AI tools for clinical answers, pharma brands must optimize for share of answer over share of voice and speed up data operations.]]&gt;</description><pubDate>Mon, 12 Oct 2026 13:06:48 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[LogiPharma USA 2026: Where Cold Chain Expertise Gaps Become Product Risk]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/logipharma-usa-2026-cold-chain-expertise-gaps-product-risk</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/logipharma-usa-2026-cold-chain-expertise-gaps-product-risk</guid><description>&lt;![CDATA[At LogiPharma USA 2026, Cold Chain Technologies&apos; TJ Rizzo explains how gaps in end-to-end cold chain expertise create risk for advanced therapies.]]&gt;</description><pubDate>Fri, 09 Oct 2026 15:46:17 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Why Securing Pharma Freight Starts With Broker and Carrier SOPs]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/why-securing-pharma-freight-starts-with-broker-and-carrier-sops</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/why-securing-pharma-freight-starts-with-broker-and-carrier-sops</guid><description>&lt;![CDATA[Octapharma USA&apos;s Kerem Tokel explains how tariffs and DSCSA are affecting how stolen pharma loads are resold, and why partner SOPs matter.]]&gt;</description><pubDate>Fri, 09 Oct 2026 13:40:11 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Supply Chain Visibility Needs Context Before AI, Says PAXAFE’s Mark Talens]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/supply-chain-visibility-needs-context-before-ai-paxafe-mark-talens</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/supply-chain-visibility-needs-context-before-ai-paxafe-mark-talens</guid><description>&lt;![CDATA[At LogiPharma USA 2026, Mark Talens explains where pharma gains the most from shared distribution visibility.]]&gt;</description><pubDate>Thu, 08 Oct 2026 17:18:42 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Pharma Pulse: PhRMA Sues to Block GLOBE Model and Bayer&apos;s $2.2B Ohio Site]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/pharma-pulse-phrma-sues-to-block-globe-model-and-bayer-s-2-2b-ohio-site</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/pharma-pulse-phrma-sues-to-block-globe-model-and-bayer-s-2-2b-ohio-site</guid><description>&lt;![CDATA[In this week&apos;s Pharma Pulse, PhRMA sues to block CMS&apos;s GLOBE pricing model, WFS opens a temperature-controlled cargo terminal in Lyon and Bayer commits $2.2 billion to a new Ohio manufacturing site.]]&gt;</description><pubDate>Thu, 08 Oct 2026 13:35:33 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Pharma Rethinks Supply Chain Planning as Disruptions Mount]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/pharma-rethinks-supply-chain-planning-as-disruptions-mount</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/pharma-rethinks-supply-chain-planning-as-disruptions-mount</guid><description>&lt;![CDATA[Freehand CEO Nitin Jayakrishnan explains why pharma manufacturers are trading long-term plans for operating models built to sense and pivot.]]&gt;</description><pubDate>Wed, 07 Oct 2026 17:17:04 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Why PhRMA Sued to Block Medicare&apos;s GLOBE Pricing Model]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/why-phrma-sued-to-block-medicares-globe-pricing-model</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/why-phrma-sued-to-block-medicares-globe-pricing-model</guid><description>&lt;![CDATA[PhRMA&apos;s lawsuit argues CMS overstepped its demonstration authority by tying Medicare Part B rebates to international prices.]]&gt;</description><pubDate>Wed, 07 Oct 2026 15:59:16 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Embedding Artificial Intelligence within Pharma Supply Chains]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/embedding-artificial-intelligence-within-pharma-supply-chains</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/embedding-artificial-intelligence-within-pharma-supply-chains</guid><description>&lt;![CDATA[Adding artificial intelligence (AI) to legacy pharma supply chain systems requires auditable human intelligence to fix data and trust gaps.]]&gt;</description><pubDate>Wed, 07 Oct 2026 15:29:35 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Why Pharma Is Automating for Resilience]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/why-pharma-is-automating-for-resilience</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/why-pharma-is-automating-for-resilience</guid><description>&lt;![CDATA[At LogiPharma USA 2026, Swisslog&apos;s Garrett Freeman explains how onshoring, geopolitical risk and a shifting product mix are driving supply chain automation.]]&gt;</description><pubDate>Wed, 07 Oct 2026 14:42:02 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[LogiPharma USA 2026: Data Readiness Must Come Before AI]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/logipharma-usa-2026-data-readiness-must-come-before-ai</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/logipharma-usa-2026-data-readiness-must-come-before-ai</guid><description>&lt;![CDATA[At LogiPharma USA 2026, quality leaders explained why connected data, risk-based prioritization, and human accountability must come before AI in supply chain compliance.]]&gt;</description><pubDate>Tue, 06 Oct 2026 18:28:43 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Q&amp;A: Software&apos;s Next Role In Pharma Supply Chains]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/q-a-software-s-next-role-in-pharma-supply-chains</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/q-a-software-s-next-role-in-pharma-supply-chains</guid><description>&lt;![CDATA[Swisslog&apos;s Mark Beers discusses how software helps pharma supply chains adapt to shifting portfolios, strengthen inventory verification and build trust.]]&gt;</description><pubDate>Tue, 06 Oct 2026 12:59:34 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Logipharma USA 2026: Building Resilient Supply Chains at Scale]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/logipharma-usa-2026-building-resilient-supply-chains-at-scale</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/logipharma-usa-2026-building-resilient-supply-chains-at-scale</guid><description>&lt;![CDATA[At LogiPharma USA 2026, leaders from J&amp;amp;J, Sun Pharma, Accord Healthcare, and Freehand discussed visibility, redundancy tradeoffs, and AI&apos;s role in resilient pharma supply chains.]]&gt;</description><pubDate>Mon, 05 Oct 2026 17:27:20 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[How Distribution Is Evolving for Today&apos;s Targeted Therapies]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/how-distribution-is-evolving-for-today-s-targeted-therapies</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/how-distribution-is-evolving-for-today-s-targeted-therapies</guid><description>&lt;![CDATA[McKesson&apos;s Chris Van Norman previews his LogiPharma USA keynote on demand signal sharing, AI, and precision distribution for targeted therapies.]]&gt;</description><pubDate>Mon, 05 Oct 2026 13:01:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[What to Watch at LogiPharma: Resilience, Practical AI and New Peer Formats]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/what-to-watch-at-logipharma-usa-2026</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/what-to-watch-at-logipharma-usa-2026</guid><description>&lt;![CDATA[LogiPharma&apos;s Charleen Ring and McKesson&apos;s Chris Van Norman preview the 2026 agenda, sessions to prioritize and a day two fireside chat.]]&gt;</description><pubDate>Fri, 02 Oct 2026 14:37:25 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Cardinal Health, McKesson Extend CVS Distribution Deals to 2032]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/cardinal-health-mckesson-extend-cvs-distribution-deals-to-2032</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/cardinal-health-mckesson-extend-cvs-distribution-deals-to-2032</guid><description>&lt;![CDATA[Cardinal Health and McKesson moved to extend CVS Health distribution deals through June 2032, retaining their largest customer pending final contracts.]]&gt;</description><pubDate>Fri, 02 Oct 2026 13:15:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Three Details Worth a Second Read]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/three-details-worth-a-second-read</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/three-details-worth-a-second-read</guid><description>&lt;![CDATA[Inside the October 2026 issue: why splitting MMR takes years, why payers cite a price that does not bind them, and what pricing rules broke.]]&gt;</description><pubDate>Thu, 01 Oct 2026 15:25:21 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Decades of Playbook, Under Review]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/decades-of-playbook-under-review</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/decades-of-playbook-under-review</guid><description>&lt;![CDATA[Mike Hennessy Jr. on the commercial assumptions being rewritten across pricing, patient engagement and supply chain in PC&apos;s October 2026 print issue.]]&gt;</description><pubDate>Thu, 01 Oct 2026 15:18:49 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Doceree CEO: AI Should Extend the Field Force, Not Replace It]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/doceree-ceo-ai-should-extend-the-field-force-not-replace-it</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/doceree-ceo-ai-should-extend-the-field-force-not-replace-it</guid><description>&lt;![CDATA[In this Q&amp;amp;A, Doceree CEO Harshit Jain, MD, explains why AI should inform prescribing decisions, not drive them, and how sales reps own relationships while AI extends reach.]]&gt;</description><pubDate>Thu, 01 Oct 2026 14:52:40 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Your Patient Support Data Shows What Happened. Can It Tell You Why?]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/your-patient-support-data-shows-what-happened-can-it-tell-you-why-</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/your-patient-support-data-shows-what-happened-can-it-tell-you-why-</guid><description>&lt;![CDATA[Patient support data that is trusted, connected and delivered into field workflows can move access teams from reporting to faster patient intervention.]]&gt;</description><pubDate>Thu, 01 Oct 2026 12:32:36 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Pharma Pulse: EU&apos;s Pharma Package and Specialty Drug Tariff Exemptions]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/pharma-pulse-eu-s-pharma-package-and-specialty-drug-tariff-exemptions</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/pharma-pulse-eu-s-pharma-package-and-specialty-drug-tariff-exemptions</guid><description>&lt;![CDATA[In this week&apos;s Pharma Pulse, the EU Council adopts the &quot;pharma package,&quot; Commerce details 0% tariffs for certain drugs and Sharp expands autoinjector assembly capacity.]]&gt;</description><pubDate>Wed, 30 Sep 2026 17:48:36 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[How the GLP-1 Boom Stress-Tests the Pharma Cold Chain]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/how-the-glp-1-boom-stress-tests-the-pharma-cold-chain</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/how-the-glp-1-boom-stress-tests-the-pharma-cold-chain</guid><description>&lt;![CDATA[GLP-1 demand is straining pharma cold chain capacity, from tighter temperature thresholds and rising load rejections to fuel costs and trailer backlogs.]]&gt;</description><pubDate>Wed, 30 Sep 2026 12:50:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[GLP-1 Payment Risks: What Pharmacies Should Review with Their Processor ]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/glp-1-payment-risks-what-pharmacies-should-review-with-their-processor</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/glp-1-payment-risks-what-pharmacies-should-review-with-their-processor</guid><description>&lt;![CDATA[As more pharmacies dispense GLP-1s, payment processor reviews, higher fees and account closures are emerging as an overlooked point of friction in the access channel.]]&gt;</description><pubDate>Tue, 29 Sep 2026 14:01:54 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Why Waltz Health, Fresenius Kabi Are Taking Biosimilars Direct]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/why-waltz-health-fresenius-kabi-are-taking-biosimilars-direct</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/why-waltz-health-fresenius-kabi-are-taking-biosimilars-direct</guid><description>&lt;![CDATA[Waltz Health and Fresenius Kabi will offer three biosimilars through a direct-to-payer model that bypasses traditional wholesaler and PBM rebate channels.]]&gt;</description><pubDate>Tue, 29 Sep 2026 13:00:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Cold Chain Consolidation Continues as Eutecma Acquires Tempaid]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/cold-chain-consolidation-continues-as-eutecma-acquires-tempaid</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/cold-chain-consolidation-continues-as-eutecma-acquires-tempaid</guid><description>&lt;![CDATA[Eutecma&apos;s Tempaid buy pairs reusable bulk shippers with last-mile mailers as smaller, more frequent refrigerated shipments reshape demand.]]&gt;</description><pubDate>Mon, 28 Sep 2026 15:47:21 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Q&amp;A: Will National Licensure Simplify Distributor Compliance?]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/q-a-will-national-licensure-simplify-distributor-compliance-</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/q-a-will-national-licensure-simplify-distributor-compliance-</guid><description>&lt;![CDATA[HDA&apos;s Kala Shankle says a federal licensure baseline could bring real efficiency gains for wholesale distributors and 3PLs, but only if state requirements align and every stakeholder moves on the same timeline.]]&gt;</description><pubDate>Mon, 28 Sep 2026 12:49:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[High Value Freight in a Changing Risk Environment.]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/high-value-freight-in-a-changing-risk-environment</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/high-value-freight-in-a-changing-risk-environment</guid><description>&lt;![CDATA[High-value freight is moving through a more complex risk environment. This whitepaper explores how tighter capacity, rising cargo theft severity, freight fraud, and greater liability scrutiny are reshaping transportation strategy. It also outlines a modern approach to carrier assessment, risk-based controls, and balancing capacity with accountability for shippers of critical, high-consequence freight.]]&gt;</description><pubDate>Mon, 28 Sep 2026 04:46:00 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[Why Early, Big-Picture Planning Is Key to Execution Across the CGT Lifecycle]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/why-early-big-picture-planning-is-key-to-execution-across-the-cgt-lifecycle</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/why-early-big-picture-planning-is-key-to-execution-across-the-cgt-lifecycle</guid><description>&lt;![CDATA[Learn how early regulatory, evidence, manufacturing, and EU access planning keeps CGT launches on track, from CoI logistics to payer coverage.]]&gt;</description><pubDate>Fri, 25 Sep 2026 20:29:46 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item><item><title>&lt;![CDATA[FAQ: What Comes Next for the 340B Rebate Pilot]]&gt;</title><link>https://www.pharmaceuticalcommerce.com/view/faq-what-comes-next-for-the-340b-rebate-pilot</link><guid isPermaLink="true">https://www.pharmaceuticalcommerce.com/view/faq-what-comes-next-for-the-340b-rebate-pilot</guid><description>&lt;![CDATA[With HRSA&apos;s approval window now closed, attention turns to whether health system pharmacies can reconcile rebates at scale before the pilot&apos;s Jan. 1 start.]]&gt;</description><pubDate>Fri, 25 Sep 2026 14:23:31 GMT</pubDate><media:credit role="publishing company">Pharmaceutical Commerce</media:credit><category>us</category><source url="https://www.pharmaceuticalcommerce.com/rss.xml">Pharmaceutical Commerce Articles</source></item></channel></rss>